6076 - 6100 of 8715 Results
Title
Year
-
OPENTitle: LRRK2 G2019S kinase activity triggers neurotoxic NSF aggregationJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 5Start Page: 1509End Page: 1525Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awab073Best OA location URL: https://academic.oup.com/brain/article-pdf/144/5/1509/38813669/awab073.pdfCitation Count: 26
-
RESTRICTEDTitle: Erythropoietin and small molecule agonists of the tissue-protective erythropoietin receptor increase FXN expression in neuronal cells in vitro and in Fxn-deficient KIKO mice in vivoJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 123Issue #:Start Page: 34End Page: 45Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2017.05.011Citation Count: 11
-
OPENTitle: Design of a virtual longitudinal observational study in Parkinson’s disease (AT‐HOME PD)Journal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 2Start Page: 308End Page: 320Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51236Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51236Citation Count: 28
-
OPENTitle: α‐Synuclein Pathology in PRKN‐Linked Parkinson's Disease: New Insights from a Blood‐Based Seed Amplification AssayJournal Name: Annals of NeurologyPublisher: WileyVol: 95Issue #: 6Start Page: 1173End Page: 1177Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.26917Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26917Citation Count: 18
-
OPENTitle: Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson’sJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 272Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-024-12789-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-024-12789-0.pdfCitation Count: 5
-
RESTRICTEDTitle: Valbenazine as treatment for Huntington's disease choreaJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 6Start Page: 459End Page: 460Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00163-1Citation Count: 5
-
RESTRICTEDTitle: A cognitive fMRI study in non-manifesting LRRK2 and GBA carriersJournal Name: Brain Structure and FunctionPublisher: Springer Science and Business Media LLCVol: 222Issue #: 3Start Page: 1207End Page: 1218Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00429-016-1271-4Citation Count: 21
-
OPENTitle: Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional StudyJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 833End Page: 844Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.27989Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27989Citation Count: 62
-
RESTRICTEDTitle: Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurementJournal Name: Clinical Chemistry and Laboratory Medicine (CCLM)Publisher: Walter de Gruyter GmbHVol: 59Issue #: 10Start Page: 1653End Page: 1661Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1515/cclm-2020-1521Citation Count: 6
-
OPENTitle: Deep mining of oxysterols and cholestenoic acids in human plasma and cerebrospinal fluid: Quantification using isotope dilution mass spectrometryJournal Name: Analytica Chimica ActaPublisher: Elsevier BVVol: 1154Issue #:Start Page: 338259End Page: 338259Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.aca.2021.338259Best OA location URL: https://doi.org/10.1016/j.aca.2021.338259Citation Count: 28
-
OPENTitle: Analysis of a precision medicine approach to treating Parkinson's disease: Analysis of the DATATOP studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 94Issue #:Start Page: 15End Page: 21Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.11.027Best OA location URL: https://doi.org/10.1016/j.parkreldis.2021.11.027Citation Count: 7
-
OPENTitle: Bilateral globus pallidus stimulation for severe Tourette's syndrome: a double-blind, randomised crossover trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 14Issue #: 6Start Page: 595End Page: 605Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(15)00008-3Citation Count: 169
-
OPENTitle: Atrophy of the Cholinergic Basal Forebrain can Detect Presynaptic Cholinergic Loss in Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 93Issue #: 5Start Page: 991End Page: 998Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ana.26596Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26596Citation Count: 18
-
OPENTitle: Paroxysmal abdominalgia as a non-motor wearing off phenomenon in Parkinson’s disease. A case series and literature reviewJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 13Issue #:Start Page: 100368End Page: 100368Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100368Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100368Citation Count: 0
-
OPENTitle: Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic MiceJournal Name: Molecular Therapy Nucleic AcidsPublisher: Elsevier BVVol: 21Issue #:Start Page: 623End Page: 635Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.omtn.2020.06.027Best OA location URL: http://www.cell.com/article/S2162253120301888/pdfCitation Count: 37
-
RESTRICTEDTitle: Attitudes toward use and timing of deep brain stimulation: a patient’s with DBS perspectiveJournal Name: Clinical Neurology and NeurosurgeryPublisher: Elsevier BVVol: 203Issue #:Start Page: 106553End Page: 106553Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clineuro.2021.106553Citation Count: 6
-
OPENTitle: Serine/Threonine Protein Phosphatase 2A Regulates the Transport of Axonal MitochondriaJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2022.852245Best OA location URL: https://doi.org/10.3389/fncel.2022.852245Citation Count: 5
-
OPENTitle: Semisynthetic and in Vitro Phosphorylation of Alpha-Synuclein at Y39 Promotes Functional Partly Helical Membrane-Bound States Resembling Those Induced by PD MutationsJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 11Issue #: 9Start Page: 2428End Page: 2437Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.6b00539Best OA location URL: https://infoscience.epfl.ch/handle/20.500.14299/131514Citation Count: 69
-
OPENTitle: Targeting specific kinase substrates rescues increased colitis severity induced by the Crohn’s disease–linked LRRK2-N2081D variantJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 135Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci190017Best OA location URL: https://doi.org/10.1172/jci190017Citation Count: 0
-
OPENTitle: Exploring the layers of fatigue in Parkinson’s Disease: A comprehensive analysis of its prevalence and contributing factorsJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 11Issue #:Start Page: 100288End Page: 100288Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100288Best OA location URL: https://doi.org/10.1016/j.prdoa.2024.100288Citation Count: 1
-
OPENTitle: Seeding-competent early tau multimers are associated with cell type-specific transcriptional signaturesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 149Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-025-02869-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-025-02869-4.pdfCitation Count: 1
- Falls in people with Parkinson’s disease: A prospective comparison of community and home-based falls2017RESTRICTEDTitle: Falls in people with Parkinson’s disease: A prospective comparison of community and home-based fallsJournal Name: Gait & PosturePublisher: Elsevier BVVol: 55Issue #:Start Page: 62End Page: 67Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.gaitpost.2017.04.005Citation Count: 41
- Elevated cholesterol is a common phenotype for dominant and recessive ATAD3-associated disorders2024OPENTitle: Elevated cholesterol is a common phenotype for dominant and recessive ATAD3-associated disordersJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 148Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awae402Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awae402/61091141/awae402.pdfCitation Count: 1
-
RESTRICTEDTitle: Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug StrategyJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 11Start Page: 2542End Page: 2547Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00236Citation Count: 12
-
OPENTitle: Clinical severity in Parkinson’s disease is determined by decline in cortical compensationJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 3Start Page: 871End Page: 886Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awad325Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad325/51777747/awad325.pdfCitation Count: 27